Published in
Ferrata Storti Foundation, Haematologica, 9(105), p. e461-464, 2020
DOI: 10.3324/haematol.2019.230276
Links
Tools
Safety and efficacy of brentuximab vedotin as a treatment for lymphoproliferative disorders in primary immunodeficiencies
Journal article published in 2019 by
Thomas Pincez 
,
Julie Bruneau ,
Laureline Berteloot,
Eve Piekarski,
Caroline Thomas,
Ambroise Marçais,
Amélie Trinquand,
Martin Castelle,
Nicolas Garcelon,
Dominique Plantaz,
Morgane Cheminant,
Despina Moshous,
Thierry Jo Molina,
Olivier Hermine,
Elizabeth Macintyre
and other authors.
,
Julie Bruneau ,
Laureline Berteloot,
Eve Piekarski,
Caroline Thomas,
Ambroise Marçais,
Amélie Trinquand,
Martin Castelle,
Nicolas Garcelon,
Dominique Plantaz,
Morgane Cheminant,
Despina Moshous,
Thierry Jo Molina,
Olivier Hermine,
Elizabeth Macintyre
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 